Estimates Revisions Sun Pharmaceutical Industries Ltd.
Stocks
SUNPHARMA
INE044A01036
Pharmaceuticals
|
Delayed
NSE India S.E.
14:28:29 31/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,984.80 INR | +3.38% |
|
+3.92% | +15.42% |
| 08-05 | CRISIL Keeps AAA Rating on Sun Pharmaceutical's Bank Facilities | MT |
| 07-31 | Sun Pharmaceutical Industries Limited, Q1 2027 Earnings Call, Jul 31, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- SUNPHARMA Stock
- Consensus Sun Pharmaceutical Industries Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
